Ameriprise’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-254,839
| Closed | -$17.3M | – | 3809 |
|
|
2019
Q3 | $17.3M | Buy |
254,839
+14,731
| +6% | +$999K | 0.01% | 1248 |
|
|
2019
Q2 | $14M | Buy |
240,108
+92,429
| +63% | +$5.38M | 0.01% | 1458 |
|
|
2019
Q1 | $10.3M | Buy |
147,679
+42,621
| +41% | +$2.99M | ﹤0.01% | 1677 |
|
|
2018
Q4 | $6.77M | Sell |
105,058
-93,658
| -47% | -$6.03M | ﹤0.01% | 1908 |
|
|
2018
Q3 | $14M | Sell |
198,716
-330,388
| -62% | -$23.2M | ﹤0.01% | 1600 |
|
|
2018
Q2 | $26.7M | Sell |
529,104
-982,863
| -65% | -$49.5M | 0.01% | 992 |
|
|
2018
Q1 | $47.3M | Buy |
1,511,967
+1,414,051
| +1,444% | +$44.2M | 0.02% | 688 |
|
|
2017
Q4 | $3.35M | Buy |
97,916
+11,192
| +13% | +$383K | ﹤0.01% | 2384 |
|
|
2017
Q3 | $2.78M | Buy |
86,724
+5,721
| +7% | +$184K | ﹤0.01% | 2439 |
|
|
2017
Q2 | $2.64M | Buy |
81,003
+30,089
| +59% | +$979K | ﹤0.01% | 2469 |
|
|
2017
Q1 | $1.6M | Sell |
50,914
-1,978
| -4% | -$62.3K | ﹤0.01% | 2680 |
|
|
2016
Q4 | $1.55M | Buy |
52,892
+34,466
| +187% | +$1.01M | ﹤0.01% | 2751 |
|
|
2016
Q3 | $533K | Buy |
+18,426
| New | +$533K | ﹤0.01% | 3159 |
|
|
2014
Q4 | – | Sell |
-110
| Closed | -$3K | – | 4729 |
|
|
2014
Q3 | $3K | Buy |
110
+60
| +120% | +$1.64K | ﹤0.01% | 5283 |
|
|
2014
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 5395 |
|
|
2014
Q1 | $1K | Sell |
50
-82
| -62% | -$1.64K | ﹤0.01% | 5194 |
|
|
2013
Q4 | $4K | Sell |
132
-961
| -88% | -$29.1K | ﹤0.01% | 4693 |
|
|
2013
Q3 | $34K | Sell |
1,093
-80
| -7% | -$2.49K | ﹤0.01% | 4041 |
|
|
2013
Q2 | $37K | Buy |
+1,173
| New | +$37K | ﹤0.01% | 3887 |
|